Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging - PubMed (original) (raw)
Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
D F Gleason et al. J Urol. 1974 Jan.
No abstract available
Similar articles
- Orchiectomy for advanced prostatic carcinoma. A reevaluation.
Blackard CE, Byar DP, Jordan WP Jr. Blackard CE, et al. Urology. 1973 Jun;1(6):553-60. doi: 10.1016/0090-4295(73)90515-3. Urology. 1973. PMID: 4588820 Clinical Trial. No abstract available. - Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
Gleason DF, Mellinger GT; Veterans Administration Cooperative Urological Research Group. Gleason DF, et al. J Urol. 2017 Feb;197(2S):S134-S139. doi: 10.1016/j.juro.2016.10.099. Epub 2016 Dec 21. J Urol. 2017. PMID: 28012760 Clinical Trial. No abstract available. - Endocrine treatment of cancer of the prostate.
Madsen PO, Pedersen JF, Knuth OE. Madsen PO, et al. Wis Med J. 1970 Jul;69(7):177-81. Wis Med J. 1970. PMID: 4916084 Clinical Trial. No abstract available. - Current concepts concerning carcinoma of the prostate.
Skinner DG. Skinner DG. Surg Annu. 1973;5:393-406. Surg Annu. 1973. PMID: 4602222 Review. No abstract available. - Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate.
Seay TM, Blute MC, Zincke H. Seay TM, et al. Urology. 1997 Dec;50(6):833-7. doi: 10.1016/S0090-4295(97)00482-2. Urology. 1997. PMID: 9426709 Review. No abstract available.
Cited by
- Quantum dot imaging platform for single-cell molecular profiling.
Zrazhevskiy P, Gao X. Zrazhevskiy P, et al. Nat Commun. 2013;4:1619. doi: 10.1038/ncomms2635. Nat Commun. 2013. PMID: 23511483 Free PMC article. - Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling.
Brady L, Kriner M, Coleman I, Morrissey C, Roudier M, True LD, Gulati R, Plymate SR, Zhou Z, Birditt B, Meredith R, Geiss G, Hoang M, Beechem J, Nelson PS. Brady L, et al. Nat Commun. 2021 Mar 3;12(1):1426. doi: 10.1038/s41467-021-21615-4. Nat Commun. 2021. PMID: 33658518 Free PMC article. - CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.
Eminaga O, Abbas M, Hinkelammert R, Titze U, Bettendorf O, Eltze E, Ozgür E, Semjonow A. Eminaga O, et al. BMC Med Inform Decis Mak. 2012 Dec 3;12:141. doi: 10.1186/1472-6947-12-141. BMC Med Inform Decis Mak. 2012. PMID: 23206574 Free PMC article. - Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients.
Hinton BK, Fiveash JB, Wu X, Dobelbower MC, Kim RY, Jacob R. Hinton BK, et al. ISRN Oncol. 2013;2013:941269. doi: 10.1155/2013/941269. Epub 2013 Mar 7. ISRN Oncol. 2013. PMID: 23533814 Free PMC article. - Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.
Tosoian JJ, Loeb S, Epstein JI, Turkbey B, Choyke PL, Schaeffer EM. Tosoian JJ, et al. Am Soc Clin Oncol Educ Book. 2016;35:e235-45. doi: 10.1200/EDBK_159244. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249729 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources